Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2- indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-β_1-40 in the rat

Medicine & Life Sciences

• spiro(imidazo-(1,2-a)pyridine-3,2-indan)-2(3H)-one 100%
• Nootropic Agents 64%
• Amyloid 43%
• Learning 33%
• Intraventricular Infusions 18%
• Choline O-Acetyltransferase 16%
• Scopolamine 16%
• Glutathione Transferase 13%
• Nicotine 13%
• Acetylcholine 12%
• Hippocampus 10%
• Water 8%
• Basal Forebrain 8%
• Avoidance Learning 8%
• Psychology Retention 7%
• Memory Disorders 6%
• Short-Term Memory 6%
• Cholinergic Agents 6%
• Oral Administration 5%
• Cognitive Dysfunction 5%
• Alzheimer Disease 5%
• Oxidative Stress 4%
• Therapeutics 1%